The Hindu Business Line : Dabur Pharma eyes global buys

New Delhi May 17 Dabur Pharma, rich from the recent divestment of its non-oncology business, is looking to acquire an international distribution and marketing company.

"China is one of the geographical markets we are focusing on. It is one of the regions under close scrutiny," said Mr Ajay Vij, CEO, adding that the company was yet to finalise a target. "However, we are also considering options in the Asia-Pacific, Japan, and even the US and Europe," he added.

In April, the company completed divestment of its non-oncology formulations division to Alembic for Rs 159 crore.

Mr Vij had then told Business Line: "Taking into account our entry into the US and European markets and our ambition to get into countries like Japan, focusing on oncology seemed to have been the logical thing to do. Growth will come in two forms, organic and through acquisitions, and the cash raised by this sale will come in handy."

The company recently also established a subsidiary in the US that will be responsible for sales, marketing and distribution of its anti-cancer products.

Having discontinued the agreement with US pharma company Hospira, Dabur Pharma is confident of doing good business on its own in the US.

In January, the company acquired the entire oncology sales and distribution business from its partner in Thailand, Biosciences Company Ltd, for an undisclosed amount.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Bajaj forms 2 separate cos for auto, financial services

Entry-level BPO salaries steadying

Fighting the inflation blaze

`Fiscal sops alone will not attract industry'

IT, ITeS cos bid to offset impact of rising rupee

Dabur Pharma eyes global buys

Tea output drops sharply in March; exports recover

Bajaj Auto Q4 net down 4% at Rs 308 cr

Tata Steel Q4 net surges 41%

Some relief for investors from two wheeler woes

Fallout of SC ruling: 49 new GM cotton strains cleared

HDFC Bank may enter market for raising Rs 4,200 cr

Barclays goes to non-metro centres; launches three retail branches

A new journey begins for Bajaj brothers